Japanese Society for Palliative Medicine
News Letter No.59
May 2013  59
Journal Watch
東北大学大学院 緩和ケア看護学分野  佐藤 一樹
(レビュー担当:宮下 光令、佐藤 一樹、清水 恵)



【N Engl J Med. 2012;367(23-26), 2013;368(1-9)】

【Lancet. 2012;380(9857-9859), 2013;381(9860-9867)】

【Lancet Oncol. 2012;13(12), 2013;14(1-2)】

【JAMA. 2012;308(21-24), 2013;309(1-8)】
米国の高齢患者の死亡場所、療養場所とその移動:2000 年〜 2009 年での変化

Teno JM, Gozalo PL, Bynum JP, Leland NE, Miller SC, Morden NE, Scupp T, Goodman DC, Mor V. Change in end-of-life care for Medicare benefi ciaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009.JAMA. 2013;309(5):470-7.

【Arch Intern Med. 2012;172(22), JAMA Intern Med. 2013;173(1-4)】

Lazzarino AI, Hamer M, Stamatakis E, Steptoe A. The combined association of psychological distress and socioeconomic status with all-cause mortality: a national cohort study. JAMA Intern Med. 2013;173(1):22-7.

Gomes T, Redelmeier DA, Juurlink DN, Dhalla IA, Camacho X, Mamdani MM. Opioid dose and risk of road trauma in Canada: a population-based study. JAMA Intern Med. 2013;173(3):196-201.

Yoong J, Park ER, Greer JA, Jackson VA, Gallagher ER, Pirl WF, Back AL, Temel JS. Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med. 2013;173(4):283-90.

【BMJ. 2012;345(7885-7888), 2013;346(7889-7896)】

Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.

【BMJ Support Palliat Care. 2012;2(4)】
肺がん患者のQOL に対する喫煙の影響:系統的レビュー

Rowland C, Eiser C, Rowe R, Danson S. The eff ect of smoking on health-related quality of life in lung cancer patients:a systematic review. BMJ Support Palliat Care. 2012;2(4):312-318.

Shane Sinclair S, Shelley Raffi n Bouchal SR, Harvey Chochinov H, Neil Hagen N, Susan McClement S. Spiritual care:how to do it. BMJ Support Palliat Care. 2012;2(4):319-327.

Centeno C, Sanz A, Cuervo MA, Ramos D, Hernansanz S, Gonzalez J, Almaraz MJ, Lama M, Vara F, Nabal M,Pascual A. Multicentre, double-blind, randomised placebo-controlled clinical trial on the effi cacy of methylphenidate on depressive symptoms in advanced cancer patients. BMJ Support Palliat Care. 2012;2(4):328-333.

Hasselaar J, Engels Y, Menten J, Jaspers B, Vissers K. The burden of non-acute dying on society: dying of cancer and chronic disease in the European Union. BMJ Support Palliat Care. 2012;2(4):334-338.

Cobb M, Dowrick C, Lloyd-Williams M. Understanding spirituality: a synoptic view. BMJ Support Palliat Care.2012;2(4):339-343.

Hwang JP, Roundtree AK, Giralt SA, Suarez-Almazor M. Late eff ects and healthcare needs of survivors of allogeneic stem cell transplantation: a qualitative study. BMJ Support Palliat Care. 2012;2(4):344-350.

Fladvad T, Fayers P, Skorpen F, Kaasa S, Klepstad P. Lack of association between genetic variability and multiple pain-related outcomes in a large cohort of patients with advanced cancer: the European Pharmacogenetic Opioid Study (EPOS). BMJ Support Palliat Care. 2012;2(4):351-355.

Tuca-Rodriguez A, Gomez-Batiste X, Espinosa-Rojas J, Martinez-Munoz M, Codorniu N, Porta-Sales J. Structure, organisation and clinical outcomes in cancer patients of hospital support teams in Spain. BMJ Support Palliat Care. 2012;2(4):356-362.

Pilot study of the impact of massage therapy on sources and levels of distress in brain tumour patients. Keir ST,Saling JR. BMJ Support Palliat Care. 2012;2(4):363-366.

Consumer Quality Index Palliative Care.Claessen SJ, Francke AL, Sixma HJ, de Veer AJ, Deliens L. Measuring patients’ experiences with palliative care: the Consumer Quality Index Palliative Care. BMJ Support Palliat Care. 2012;2(4):367-372.

【Ann Intern Med. 2012;157(11-12), 2013;158(1-4)】

Coffi n PO, Sullivan SD. Cost-eff ectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158(1):1-9.

【J Clin Oncol. 2012;30(34-36), 2013;31(1-6)】

Cousino MK, Zyzanski SJ, Yamokoski AD, Hazen RA, Baker JN, Noll RB, Rheingold SR, Geyer JR, Alexander SC,Drotar D, Kodish ED. Communicating and understanding the purpose of pediatric phase I cancer trials. J Clin Oncol.2012;30(35):4367-72.

Higginson IJ, Gao W. Opioid prescribing for cancer pain during the last 3 months of life: associated factors and 9-year trends in a nationwide United kingdom cohort study. J Clin Oncol. 2012;30(35):4373-9.

Wentlandt K, Krzyzanowska MK, Swami N, Rodin GM, Le LW, Zimmermann C. Referral practices of oncologists to specialized palliative care. J Clin Oncol. 2012;30(35):4380-6.

Mack JW, Cronin A, Keating NL, Taback N, Huskamp HA, Malin JL, Earle CC, Weeks JC. Associations Between End-of-Life Discussion Characteristics and Care Received Near Death: A Prospective Cohort Study. J Clin Oncol. 2012;30(35):4387-95.

Molassiotis A, Bardy J, Finnegan-John J, Mackereth P, Ryder DW, Filshie J, Ream E, Richardson A. Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial. J Clin Oncol. 2012;30(36):4470-6.

Bruera E, Hui D, Dalal S, Torres-Vigil I, Trumble J, Roosth J, Krauter S, Strickland C, Unger K, Palmer JL, Allo J,Frisbee-Hume S, Tarleton K. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol. 2013;31(1):111-8.

Roth BJ, Krilov L, Adams S, Aghajanian CA, Bach P, Braiteh F, Brose MS, Ellis LM, Erba H, George DJ, Gilbert MR,Jacobson JO, Larsen EC, Lichtman SM, Partridge AH, Patel JD, Quinn DI, Robison LL, von Roenn JH, Samlowski W, Schwartz GK, Vogelzang NJ. Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology. J Clin Oncol. 2013;31(1):131-61.

Smith SK, Mayer DK, Zimmerman S, Williams CS, Benecha H, Ganz PA, Edwards LJ, Abernethy AP. Quality of life among long-term survivors of non-Hodgkin lymphoma: a follow-up study. J Clin Oncol. 2013;31(2):272-9.

Volandes AE, Paasche-Orlow MK, Mitchell SL, El-Jawahri A, Davis AD, Barry MJ, Hartshorn KL, Jackson VA,Gillick MR, Walker-Corkery ES, Chang Y, Lopez L, Kemeny M, Bulone L, Mann E, Misra S, Peachey M, Abbo ED,Eichler AF, Epstein AS, Noy A, Levin TT, Temel JS. Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer. J Clin Oncol. 2013;31(3):380-6.

Balboni MJ, Sullivan A, Amobi A, Phelps AC, Gorman DP, Zollfrank A, Peteet JR, Prigerson HG, Vanderweele TJ, Balboni TA. Why is spiritual care infrequent at the end of life? Spiritual care perceptions among patients, nurses, and physicians and the role of training. J Clin Oncol. 2013;31(4):461-7.

Chen AB, Cronin A, Weeks JC, Chrischilles EA, Malin J, Hayman JA, Schrag D. Palliative Radiation Therapy Practice in Patients With Metastatic Non-Small-Cell Lung Cancer: A Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol. 2013;31(5):558-64.

ASCO statement:質の高いがんサバイバーケア
McCabe MS, Bhatia S, Oeffi nger KC, Reaman GH, Tyne C, Wollins DS, Hudson MM. American society of clinical oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013;31(5):631-40.

Temel JS, Greer JA, Gallagher ER, Jackson VA, Lennes IT, Muzikansky A, Park ER, Pirl WF. Electronic prompt to improve outpatient code status documentation for patients with advanced lung cancer. J Clin Oncol. 2013;31(6):710-5.

de Raaf PJ, de Klerk C, Timman R, Busschbach JJ, Oldenmenger WH, van der Rijt CC. Systematic monitoring and treatment of physical symptoms to alleviate fatigue in patients with advanced cancer: a randomized controlled trial. J Clin Oncol. 2013;31(6):716-23.

がん患者の心理的苦痛やQOL に対する精神腫瘍学的介入の有効性:系統的レビュー
Faller H, Schuler M, Richard M, Heckl U, Weis J, Kuff ner R. Eff ects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol. 2013;31(6):782-93.

【Ann Oncol. 2012;23(12), 2013;24(1-2)】
がん患者のQOL が化学療法の治療前・治療中・治療後で異なるか

Ediebah DE, Coens C, Maringwa JT, Quinten C, Zikos E, Ringash J, King M, Gotay C, Flechtner HH, Schmucker von Koch J, Weis J, Smit EF, Kohne CH, Bottomley A. Eff ect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients. Ann Oncol. 2013;24(1):231-7.

ホジキンリンパ腫サバイバーの晩期障害によるQOL への影響
Khimani N, Chen YH, Mauch PM, Recklitis C, Diller L, Silver B, Ng AK. Infl uence of new late eff ects on quality of life over time in Hodgkin lymphoma Survivors: a longitudinal survey study. Ann Oncol. 2013;24(1):226-30.

Bernhard J, Aldridge J, Butow PN, Zoller P, Brown R, Smith A, Juraskova I. Patient-doctor agreement on recall of clinical trial discussion across cultures. Ann Oncol. 2013;24(2):391-7.

Gwilliam B, Keeley V, Todd C, Roberts C, Gittins M, Kelly L, Barclay S, Stone P. Prognosticating in patients with advanced cancer--observational study comparing the accuracy of clinicians' and patients' estimates of survival. Ann Oncol. 2013;24(2):482-8.

骨粗しょう症評価尺度SOF による高齢がん患者の生活機能障害のスクリーニング
Luciani A, Dottorini L, Battisti N, Bertuzzi C, Caldiera S, Floriani I, Zonato S, Ferrari D, Foa P. Screening elderly cancer patients for disabilities: evaluation of study of osteoporotic fractures (SOF) index and comprehensive geriatric assessment (CGA). Ann Oncol. 2013;24(2):469-74.

終末期がん患者の予後とQOL に対する補完代替療法の効果に関する韓国のコホート研究
Yun YH, Lee MK, Park SM, Kim YA, Lee WJ, Lee KS, Choi JS, Jung KH, Do YR, Kim SY, Heo DS, Kim HT, Park SR. Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: a prospective cohort study. Ann Oncol. 2013;24(2):489-94.

Cavaletti G, Cornblath DR, Merkies IS, Postma TJ, Rossi E, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galie E, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG. The chemotherapyinduced peripheral neuropathy outcome measures standardization study: from consensus to the fi rst validity and reliability fi ndings. Ann Oncol. 2013;24(2):454-62.

Chen IC, Hsu C, Chen YC, Chien SF, Kao HF, Chang SY, Hu FC, Yeh KH. Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients. Ann Oncol. 2013;24(2):463-8. Steinmetz T, Tschechne B, Harlin O, Klement B, Franzem M, Wamhoff J, Tesch H, Rohrberg R, Marschner N.Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia. Ann Oncol. 2013;24(2):475-82.

【Eur J Cancer. 2012;48(18), 2013;49(1-3)】

【Br J Cancer. 2012;107(11-12), 2013;108(1-4)】

【Cancer. 2012;118(23-24), 2013;119(1-4)】

Butt Z, Parikh ND, Beaumont JL, Rosenbloom SK, Syrjala KL, Abernethy AP, Benson AB, 3rd, Cella D. Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers: the National Comprehensive Cancer Network Functional Assessment of Cancer Therapy (NCCN-FACT) Hepatobiliary-Pancreatic Symptom Index (NFHSI). Cancer. 2012;118(23):5997-6004.

de Raaf PJ, Sleijfer S, Lamers CH, Jager A, Gratama JW, van der Rijt CC. Infl ammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study. Cancer. 2012;118(23):6005-11. Mitchell AJ, Lord K, Slattery J, Grainger L, Symonds P. How feasible is implementation of distress screening by cancer clinicians in routine clinical care? Cancer. 2012;118(24):6260-9.

Kuppermann M, Wang G, Wong S, Blanco A, Conrad P, Nakagawa S, Terdiman J, Ladabaum U. Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome. Cancer. 2013;119(1):215-25.

Zhu J, Davis RB, Stuver SO, Berry DL, Block S, Weeks JC, Weingart SN. A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer. Cancer. 2012;118(24):6278-86.
Butt Z, Peipert J, Webster K, Chen C, Cella D. General population norms for the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI). Cancer. 2013;119(2):429-37.

Spiegle G, Al-Sukhni E, Schmocker S, Gagliardi AR, Victor JC, Baxter NN, Kennedy ED. Patient decision aids for cancer treatment: are there any alternatives? Cancer. 2013;119(1):189-200.

Song L, Chen RC, Bensen JT, Knafl GJ, Nielsen ME, Farnan L, Wallen EM, Mishel M, Pruthi RS, Mohler JL, Godley PA. Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based study. Cancer. 2013;119(2):421-8.

Lennes IT, Temel JS, Hoedt C, Meilleur A, Lamont EB. Predictors of newly diagnosed cancer patients' understanding of the goals of their care at initiation of chemotherapy. Cancer. 2013;119(3):691-9.

Rades D, Hueppe M, Schild SE. A score to identify patients with metastatic spinal cord compression who may be candidates for best supportive care. Cancer. 2013;119(4):897-903.